Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends
Background The purpose of this study was to assess treatment choices among men with prostate cancer who presented at The University of Texas MD Anderson Cancer Center multidisciplinary (MultiD) clinic compared with nationwide trends. Methods In total, 4451 men with prostate cancer who presented at t...
Gespeichert in:
| Veröffentlicht in: | Cancer 2020-02, Vol.126 (3), p.506-514 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 514 |
|---|---|
| container_issue | 3 |
| container_start_page | 506 |
| container_title | Cancer |
| container_volume | 126 |
| creator | Tang, Chad Hoffman, Karen E. Allen, Pamela K. Gabel, Molly Schreiber, David Choi, Seungtaek Chapin, Brian F. Nguyen, Quynh‐Nhu Davis, John W. Corn, Paul Logothetis, Christopher Ward, John Frank, Steven J. Navai, Neema McGuire, Sean E. Anscher, Mitchell Pisters, Louis Pettaway, Curtis A. Kumar, Rachit Linson, Patrick Tripuraneni, Prabhakar Tomaszewski, Jeffrey J. Patel, Ashish B. Augspurger, Mark Kuban, Deborah A. |
| description | Background
The purpose of this study was to assess treatment choices among men with prostate cancer who presented at The University of Texas MD Anderson Cancer Center multidisciplinary (MultiD) clinic compared with nationwide trends.
Methods
In total, 4451 men with prostate cancer who presented at the MultiD clinic from 2004 to 2016 were analyzed. To assess nationwide trends, the authors analyzed 392,710 men with prostate cancer who were diagnosed between 2004 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database. The primary endpoint was treatment choice as a function of pretreatment demographics.
Results
Univariate analyses revealed similar treatment trends in the MultiD and SEER cohorts. The use of procedural forms of definitive therapy decreased with age, including brachytherapy and prostatectomy (all P |
| doi_str_mv | 10.1002/cncr.32570 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6980273</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2338985200</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4480-c940497ed6f6c2fbe79fa54e62fd2b95095701e990fb2cd261dd2c1f72168ea93</originalsourceid><addsrcrecordid>eNp9kUFrFTEUhYMo9lnd-AMk4E6YepPJTCYbQYZqhaJQKrgLeckdmzKTjEmepf_ePF9b6sbVJeS7J-fkEPKawQkD4O9tsOmk5Z2EJ2TDQMkGmOBPyQYAhqYT7Y8j8iLn63qUvGufk6OWScF7KTbEjzEUXNaYTLqla4q5mILUmmAx0ZLQlAVDofYqeouZ-kCX3Vy889n6dfZhv2br9DbThBMmrJuOlkiDKT4GM-9VgssvybPJzBlf3c1j8v3T6eV41px_-_xl_HjeWCEGaKwSIJRE10-95dMWpZpMJ7Dnk-Nb1YGqORkqBdOWW8d75hy3bJKc9QMa1R6TDwfddbdd0NnqPplZr8kv1auOxut_b4K_0j_jb92rAbhsq8DbO4EUf-0wF30dd6kGyZq37aCGjgNU6t2BsvXPck3-8AIDva9F72vRf2up8JvHnh7Q-x4qwA7AjZ_x9j9Sevw6XhxE_wDBtZvU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2338985200</pqid></control><display><type>article</type><title>Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends</title><source>MEDLINE</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><source>Alma/SFX Local Collection</source><creator>Tang, Chad ; Hoffman, Karen E. ; Allen, Pamela K. ; Gabel, Molly ; Schreiber, David ; Choi, Seungtaek ; Chapin, Brian F. ; Nguyen, Quynh‐Nhu ; Davis, John W. ; Corn, Paul ; Logothetis, Christopher ; Ward, John ; Frank, Steven J. ; Navai, Neema ; McGuire, Sean E. ; Anscher, Mitchell ; Pisters, Louis ; Pettaway, Curtis A. ; Kumar, Rachit ; Linson, Patrick ; Tripuraneni, Prabhakar ; Tomaszewski, Jeffrey J. ; Patel, Ashish B. ; Augspurger, Mark ; Kuban, Deborah A.</creator><creatorcontrib>Tang, Chad ; Hoffman, Karen E. ; Allen, Pamela K. ; Gabel, Molly ; Schreiber, David ; Choi, Seungtaek ; Chapin, Brian F. ; Nguyen, Quynh‐Nhu ; Davis, John W. ; Corn, Paul ; Logothetis, Christopher ; Ward, John ; Frank, Steven J. ; Navai, Neema ; McGuire, Sean E. ; Anscher, Mitchell ; Pisters, Louis ; Pettaway, Curtis A. ; Kumar, Rachit ; Linson, Patrick ; Tripuraneni, Prabhakar ; Tomaszewski, Jeffrey J. ; Patel, Ashish B. ; Augspurger, Mark ; Kuban, Deborah A.</creatorcontrib><description>Background
The purpose of this study was to assess treatment choices among men with prostate cancer who presented at The University of Texas MD Anderson Cancer Center multidisciplinary (MultiD) clinic compared with nationwide trends.
Methods
In total, 4451 men with prostate cancer who presented at the MultiD clinic from 2004 to 2016 were analyzed. To assess nationwide trends, the authors analyzed 392,710 men with prostate cancer who were diagnosed between 2004 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database. The primary endpoint was treatment choice as a function of pretreatment demographics.
Results
Univariate analyses revealed similar treatment trends in the MultiD and SEER cohorts. The use of procedural forms of definitive therapy decreased with age, including brachytherapy and prostatectomy (all P < .05). Later year of diagnosis/clinic visit was associated with decreased use of definitive treatments, whereas higher risk grouping was associated with increased use (all P < .001). Patients with low‐risk disease treated at the MultiD clinic were more likely to receive nondefinitive therapy than patients in SEER, whereas the opposite trend was observed for patients with high‐risk disease, with a substantial portion of high‐risk patients in SEER not receiving definitive therapy. In the MultiD clinic, African American men with intermediate‐risk and high‐risk disease were more likely to receive definitive therapy than white men, but for SEER the opposite was true.
Conclusions
Presentation at a MultiD clinic facilitates the appropriate disposition of patients with low‐risk disease to nondefinitive strategies of patients with high‐risk disease to definitive treatment, and it may obviate the influence of race.
Presentation at a multidisciplinary clinic facilitates the appropriate disposition of low‐risk patients into nondefinitive strategies and of high‐risk patients into definitive treatment, and it may obviate the confounding influence of race. By comparison, nationwide, the disposition of patients may be confounded by pretreatment demographic factors.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.32570</identifier><identifier>PMID: 31742674</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>African Americans ; Aged ; and End Results (SEER) ; Brachytherapy ; Brachytherapy - trends ; Cancer surgery ; Cancer therapies ; Demographics ; Demography ; Epidemiology ; European Continental Ancestry Group ; Health risks ; Humans ; Male ; Medical treatment ; Middle Aged ; multidisciplinary clinic ; Oncology ; Patient Selection ; Prostate cancer ; Prostate-Specific Antigen - blood ; Prostatectomy ; Prostatectomy - trends ; Prostatic Neoplasms - blood ; Prostatic Neoplasms - epidemiology ; Prostatic Neoplasms - therapy ; Radiation therapy ; Risk ; SEER Program ; Surveillance ; treatment access ; Trends ; United States - epidemiology ; Urological surgery</subject><ispartof>Cancer, 2020-02, Vol.126 (3), p.506-514</ispartof><rights>2019 American Cancer Society</rights><rights>2019 American Cancer Society.</rights><rights>2020 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4480-c940497ed6f6c2fbe79fa54e62fd2b95095701e990fb2cd261dd2c1f72168ea93</citedby><cites>FETCH-LOGICAL-c4480-c940497ed6f6c2fbe79fa54e62fd2b95095701e990fb2cd261dd2c1f72168ea93</cites><orcidid>0000-0002-5915-1327</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.32570$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.32570$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1416,1432,27923,27924,45573,45574,46408,46832</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31742674$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Chad</creatorcontrib><creatorcontrib>Hoffman, Karen E.</creatorcontrib><creatorcontrib>Allen, Pamela K.</creatorcontrib><creatorcontrib>Gabel, Molly</creatorcontrib><creatorcontrib>Schreiber, David</creatorcontrib><creatorcontrib>Choi, Seungtaek</creatorcontrib><creatorcontrib>Chapin, Brian F.</creatorcontrib><creatorcontrib>Nguyen, Quynh‐Nhu</creatorcontrib><creatorcontrib>Davis, John W.</creatorcontrib><creatorcontrib>Corn, Paul</creatorcontrib><creatorcontrib>Logothetis, Christopher</creatorcontrib><creatorcontrib>Ward, John</creatorcontrib><creatorcontrib>Frank, Steven J.</creatorcontrib><creatorcontrib>Navai, Neema</creatorcontrib><creatorcontrib>McGuire, Sean E.</creatorcontrib><creatorcontrib>Anscher, Mitchell</creatorcontrib><creatorcontrib>Pisters, Louis</creatorcontrib><creatorcontrib>Pettaway, Curtis A.</creatorcontrib><creatorcontrib>Kumar, Rachit</creatorcontrib><creatorcontrib>Linson, Patrick</creatorcontrib><creatorcontrib>Tripuraneni, Prabhakar</creatorcontrib><creatorcontrib>Tomaszewski, Jeffrey J.</creatorcontrib><creatorcontrib>Patel, Ashish B.</creatorcontrib><creatorcontrib>Augspurger, Mark</creatorcontrib><creatorcontrib>Kuban, Deborah A.</creatorcontrib><title>Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Background
The purpose of this study was to assess treatment choices among men with prostate cancer who presented at The University of Texas MD Anderson Cancer Center multidisciplinary (MultiD) clinic compared with nationwide trends.
Methods
In total, 4451 men with prostate cancer who presented at the MultiD clinic from 2004 to 2016 were analyzed. To assess nationwide trends, the authors analyzed 392,710 men with prostate cancer who were diagnosed between 2004 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database. The primary endpoint was treatment choice as a function of pretreatment demographics.
Results
Univariate analyses revealed similar treatment trends in the MultiD and SEER cohorts. The use of procedural forms of definitive therapy decreased with age, including brachytherapy and prostatectomy (all P < .05). Later year of diagnosis/clinic visit was associated with decreased use of definitive treatments, whereas higher risk grouping was associated with increased use (all P < .001). Patients with low‐risk disease treated at the MultiD clinic were more likely to receive nondefinitive therapy than patients in SEER, whereas the opposite trend was observed for patients with high‐risk disease, with a substantial portion of high‐risk patients in SEER not receiving definitive therapy. In the MultiD clinic, African American men with intermediate‐risk and high‐risk disease were more likely to receive definitive therapy than white men, but for SEER the opposite was true.
Conclusions
Presentation at a MultiD clinic facilitates the appropriate disposition of patients with low‐risk disease to nondefinitive strategies of patients with high‐risk disease to definitive treatment, and it may obviate the influence of race.
Presentation at a multidisciplinary clinic facilitates the appropriate disposition of low‐risk patients into nondefinitive strategies and of high‐risk patients into definitive treatment, and it may obviate the confounding influence of race. By comparison, nationwide, the disposition of patients may be confounded by pretreatment demographic factors.</description><subject>African Americans</subject><subject>Aged</subject><subject>and End Results (SEER)</subject><subject>Brachytherapy</subject><subject>Brachytherapy - trends</subject><subject>Cancer surgery</subject><subject>Cancer therapies</subject><subject>Demographics</subject><subject>Demography</subject><subject>Epidemiology</subject><subject>European Continental Ancestry Group</subject><subject>Health risks</subject><subject>Humans</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>multidisciplinary clinic</subject><subject>Oncology</subject><subject>Patient Selection</subject><subject>Prostate cancer</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatectomy</subject><subject>Prostatectomy - trends</subject><subject>Prostatic Neoplasms - blood</subject><subject>Prostatic Neoplasms - epidemiology</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Radiation therapy</subject><subject>Risk</subject><subject>SEER Program</subject><subject>Surveillance</subject><subject>treatment access</subject><subject>Trends</subject><subject>United States - epidemiology</subject><subject>Urological surgery</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFrFTEUhYMo9lnd-AMk4E6YepPJTCYbQYZqhaJQKrgLeckdmzKTjEmepf_ePF9b6sbVJeS7J-fkEPKawQkD4O9tsOmk5Z2EJ2TDQMkGmOBPyQYAhqYT7Y8j8iLn63qUvGufk6OWScF7KTbEjzEUXNaYTLqla4q5mILUmmAx0ZLQlAVDofYqeouZ-kCX3Vy889n6dfZhv2br9DbThBMmrJuOlkiDKT4GM-9VgssvybPJzBlf3c1j8v3T6eV41px_-_xl_HjeWCEGaKwSIJRE10-95dMWpZpMJ7Dnk-Nb1YGqORkqBdOWW8d75hy3bJKc9QMa1R6TDwfddbdd0NnqPplZr8kv1auOxut_b4K_0j_jb92rAbhsq8DbO4EUf-0wF30dd6kGyZq37aCGjgNU6t2BsvXPck3-8AIDva9F72vRf2up8JvHnh7Q-x4qwA7AjZ_x9j9Sevw6XhxE_wDBtZvU</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Tang, Chad</creator><creator>Hoffman, Karen E.</creator><creator>Allen, Pamela K.</creator><creator>Gabel, Molly</creator><creator>Schreiber, David</creator><creator>Choi, Seungtaek</creator><creator>Chapin, Brian F.</creator><creator>Nguyen, Quynh‐Nhu</creator><creator>Davis, John W.</creator><creator>Corn, Paul</creator><creator>Logothetis, Christopher</creator><creator>Ward, John</creator><creator>Frank, Steven J.</creator><creator>Navai, Neema</creator><creator>McGuire, Sean E.</creator><creator>Anscher, Mitchell</creator><creator>Pisters, Louis</creator><creator>Pettaway, Curtis A.</creator><creator>Kumar, Rachit</creator><creator>Linson, Patrick</creator><creator>Tripuraneni, Prabhakar</creator><creator>Tomaszewski, Jeffrey J.</creator><creator>Patel, Ashish B.</creator><creator>Augspurger, Mark</creator><creator>Kuban, Deborah A.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5915-1327</orcidid></search><sort><creationdate>20200201</creationdate><title>Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends</title><author>Tang, Chad ; Hoffman, Karen E. ; Allen, Pamela K. ; Gabel, Molly ; Schreiber, David ; Choi, Seungtaek ; Chapin, Brian F. ; Nguyen, Quynh‐Nhu ; Davis, John W. ; Corn, Paul ; Logothetis, Christopher ; Ward, John ; Frank, Steven J. ; Navai, Neema ; McGuire, Sean E. ; Anscher, Mitchell ; Pisters, Louis ; Pettaway, Curtis A. ; Kumar, Rachit ; Linson, Patrick ; Tripuraneni, Prabhakar ; Tomaszewski, Jeffrey J. ; Patel, Ashish B. ; Augspurger, Mark ; Kuban, Deborah A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4480-c940497ed6f6c2fbe79fa54e62fd2b95095701e990fb2cd261dd2c1f72168ea93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>African Americans</topic><topic>Aged</topic><topic>and End Results (SEER)</topic><topic>Brachytherapy</topic><topic>Brachytherapy - trends</topic><topic>Cancer surgery</topic><topic>Cancer therapies</topic><topic>Demographics</topic><topic>Demography</topic><topic>Epidemiology</topic><topic>European Continental Ancestry Group</topic><topic>Health risks</topic><topic>Humans</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>multidisciplinary clinic</topic><topic>Oncology</topic><topic>Patient Selection</topic><topic>Prostate cancer</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatectomy</topic><topic>Prostatectomy - trends</topic><topic>Prostatic Neoplasms - blood</topic><topic>Prostatic Neoplasms - epidemiology</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Radiation therapy</topic><topic>Risk</topic><topic>SEER Program</topic><topic>Surveillance</topic><topic>treatment access</topic><topic>Trends</topic><topic>United States - epidemiology</topic><topic>Urological surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tang, Chad</creatorcontrib><creatorcontrib>Hoffman, Karen E.</creatorcontrib><creatorcontrib>Allen, Pamela K.</creatorcontrib><creatorcontrib>Gabel, Molly</creatorcontrib><creatorcontrib>Schreiber, David</creatorcontrib><creatorcontrib>Choi, Seungtaek</creatorcontrib><creatorcontrib>Chapin, Brian F.</creatorcontrib><creatorcontrib>Nguyen, Quynh‐Nhu</creatorcontrib><creatorcontrib>Davis, John W.</creatorcontrib><creatorcontrib>Corn, Paul</creatorcontrib><creatorcontrib>Logothetis, Christopher</creatorcontrib><creatorcontrib>Ward, John</creatorcontrib><creatorcontrib>Frank, Steven J.</creatorcontrib><creatorcontrib>Navai, Neema</creatorcontrib><creatorcontrib>McGuire, Sean E.</creatorcontrib><creatorcontrib>Anscher, Mitchell</creatorcontrib><creatorcontrib>Pisters, Louis</creatorcontrib><creatorcontrib>Pettaway, Curtis A.</creatorcontrib><creatorcontrib>Kumar, Rachit</creatorcontrib><creatorcontrib>Linson, Patrick</creatorcontrib><creatorcontrib>Tripuraneni, Prabhakar</creatorcontrib><creatorcontrib>Tomaszewski, Jeffrey J.</creatorcontrib><creatorcontrib>Patel, Ashish B.</creatorcontrib><creatorcontrib>Augspurger, Mark</creatorcontrib><creatorcontrib>Kuban, Deborah A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Chad</au><au>Hoffman, Karen E.</au><au>Allen, Pamela K.</au><au>Gabel, Molly</au><au>Schreiber, David</au><au>Choi, Seungtaek</au><au>Chapin, Brian F.</au><au>Nguyen, Quynh‐Nhu</au><au>Davis, John W.</au><au>Corn, Paul</au><au>Logothetis, Christopher</au><au>Ward, John</au><au>Frank, Steven J.</au><au>Navai, Neema</au><au>McGuire, Sean E.</au><au>Anscher, Mitchell</au><au>Pisters, Louis</au><au>Pettaway, Curtis A.</au><au>Kumar, Rachit</au><au>Linson, Patrick</au><au>Tripuraneni, Prabhakar</au><au>Tomaszewski, Jeffrey J.</au><au>Patel, Ashish B.</au><au>Augspurger, Mark</au><au>Kuban, Deborah A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>126</volume><issue>3</issue><spage>506</spage><epage>514</epage><pages>506-514</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Background
The purpose of this study was to assess treatment choices among men with prostate cancer who presented at The University of Texas MD Anderson Cancer Center multidisciplinary (MultiD) clinic compared with nationwide trends.
Methods
In total, 4451 men with prostate cancer who presented at the MultiD clinic from 2004 to 2016 were analyzed. To assess nationwide trends, the authors analyzed 392,710 men with prostate cancer who were diagnosed between 2004 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database. The primary endpoint was treatment choice as a function of pretreatment demographics.
Results
Univariate analyses revealed similar treatment trends in the MultiD and SEER cohorts. The use of procedural forms of definitive therapy decreased with age, including brachytherapy and prostatectomy (all P < .05). Later year of diagnosis/clinic visit was associated with decreased use of definitive treatments, whereas higher risk grouping was associated with increased use (all P < .001). Patients with low‐risk disease treated at the MultiD clinic were more likely to receive nondefinitive therapy than patients in SEER, whereas the opposite trend was observed for patients with high‐risk disease, with a substantial portion of high‐risk patients in SEER not receiving definitive therapy. In the MultiD clinic, African American men with intermediate‐risk and high‐risk disease were more likely to receive definitive therapy than white men, but for SEER the opposite was true.
Conclusions
Presentation at a MultiD clinic facilitates the appropriate disposition of patients with low‐risk disease to nondefinitive strategies of patients with high‐risk disease to definitive treatment, and it may obviate the influence of race.
Presentation at a multidisciplinary clinic facilitates the appropriate disposition of low‐risk patients into nondefinitive strategies and of high‐risk patients into definitive treatment, and it may obviate the confounding influence of race. By comparison, nationwide, the disposition of patients may be confounded by pretreatment demographic factors.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31742674</pmid><doi>10.1002/cncr.32570</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-5915-1327</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0008-543X |
| ispartof | Cancer, 2020-02, Vol.126 (3), p.506-514 |
| issn | 0008-543X 1097-0142 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6980273 |
| source | MEDLINE; Wiley Free Content; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals; Alma/SFX Local Collection |
| subjects | African Americans Aged and End Results (SEER) Brachytherapy Brachytherapy - trends Cancer surgery Cancer therapies Demographics Demography Epidemiology European Continental Ancestry Group Health risks Humans Male Medical treatment Middle Aged multidisciplinary clinic Oncology Patient Selection Prostate cancer Prostate-Specific Antigen - blood Prostatectomy Prostatectomy - trends Prostatic Neoplasms - blood Prostatic Neoplasms - epidemiology Prostatic Neoplasms - therapy Radiation therapy Risk SEER Program Surveillance treatment access Trends United States - epidemiology Urological surgery |
| title | Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T07%3A46%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contemporary%20prostate%20cancer%20treatment%20choices%20in%20multidisciplinary%20clinics%20referenced%20to%20national%20trends&rft.jtitle=Cancer&rft.au=Tang,%20Chad&rft.date=2020-02-01&rft.volume=126&rft.issue=3&rft.spage=506&rft.epage=514&rft.pages=506-514&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.32570&rft_dat=%3Cproquest_pubme%3E2338985200%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2338985200&rft_id=info:pmid/31742674&rfr_iscdi=true |